Literature DB >> 27716961

Left ventricular stiffness estimated by diastolic wall strain is associated with paroxysmal atrial fibrillation in structurally normal hearts.

Shunsuke Uetake1, Mitsunori Maruyama1, Teppei Yamamoto2, Katsuhito Kato1, Yasushi Miyauchi1, Yoshihiko Seino1, Wataru Shimizu2.   

Abstract

BACKGROUND: Left ventricular (LV) diastolic dysfunction depends on an impaired relaxation and stiffness. Abnormal LV relaxation contributes to the development of atrial fibrillation (AF), but the role of LV stiffness in AF remains unclear. HYPOTHESIS: Diastolic wall strain (DWS), a load-independent, noninvasive direct measure of LV stiffness, correlates with prevalent AF.
METHODS: This study included 328 consecutive subjects with structurally normal hearts: 164 paroxysmal AF patients and 164 age- and sex-matched (1:1) controls. We calculated the DWS from the M-mode echocardiographic measurements of the LV posterior wall thickness at end-systole and end-diastole during sinus rhythm.
RESULTS: The DWS was lower in the AF patients (0.35 ± 0.07) than in the controls (0.41 ± 0.06; P < 0.001). After adjusting for the risk factors of AF using a conditional logistic regression analysis, a history of hypertension, plasma brain-type natriuretic peptide level, and DWS were independently associated with AF prevalence, whereas body mass index, LV mass index, left atrial volume, and any conventional indices of the diastolic function were not. A low DWS (<0.380) was the strongest indicator of AF (odds ratio: 6.22, 95% confidence interval: 3.08-14.2, P < 0.001).
CONCLUSIONS: Increased LV stiffness estimated by DWS was a strong determinant of the prevalence of AF. LV stiffness may play a role in the pathogenesis of paroxysmal AF in structurally normal hearts.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atrial fibrillation; Diastolic dysfunction; Diastolic wall strain; Stiffness

Mesh:

Year:  2016        PMID: 27716961      PMCID: PMC6490820          DOI: 10.1002/clc.22595

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  16 in total

Review 1.  Recommendations for chamber quantification.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack Shanewise; Scott Solomon; Kirk T Spencer; Martin St John Sutton; William Stewart
Journal:  Eur J Echocardiogr       Date:  2006-02-02

2.  Transition from asymptomatic diastolic dysfunction to heart failure with preserved ejection fraction: roles of systolic function and ventricular distensibility.

Authors:  Yoshihiro Aizawa; Yasushi Sakata; Toshiaki Mano; Yasuharu Takeda; Tomohito Ohtani; Shunsuke Tamaki; Yosuke Omori; Yasumasa Tsukamoto; Atsushi Hirayama; Issei Komuro; Kazuhiro Yamamoto
Journal:  Circ J       Date:  2011-01-27       Impact factor: 2.993

3.  Noninvasive assessment of wall distensibility with the evaluation of diastolic epicardial movement.

Authors:  Yasuharu Takeda; Yasushi Sakata; Mitsuru Higashimori; Toshiaki Mano; Mayu Nishio; Tomohito Ohtani; Masatsugu Hori; Tohru Masuyama; Makoto Kaneko; Kazuhiro Yamamoto
Journal:  J Card Fail       Date:  2009-02       Impact factor: 5.712

Review 4.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa
Journal:  Eur J Echocardiogr       Date:  2009-03

5.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women.

Authors:  Teresa S M Tsang; Bernard J Gersh; Christopher P Appleton; A Jamil Tajik; Marion E Barnes; Kent R Bailey; Jae K Oh; Cynthia Leibson; Samantha C Montgomery; James B Seward
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

9.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

10.  Blood pressure control and risk of incident atrial fibrillation.

Authors:  M C Thomas; S Dublin; R C Kaplan; N L Glazer; T Lumley; W T Longstreth; N L Smith; B M Psaty; D S Siscovick; S R Heckbert
Journal:  Am J Hypertens       Date:  2008-08-28       Impact factor: 2.689

View more
  2 in total

1.  Lower diastolic wall strain is associated with coronary revascularization in patients with stable angina.

Authors:  Jaehuk Choi; Min-Kyung Kang; Chaehoon Han; Sang Muk Hwang; Sung Gu Jung; Han-Kyul Kim; Kwang Jin Chun; Seonghoon Choi; Jung Rae Cho; Namho Lee
Journal:  BMC Cardiovasc Disord       Date:  2017-12-28       Impact factor: 2.298

2.  Evaluation of Coronary Artery Disease in Patients with Atrial Fibrillation by Cardiac Computed Tomography for Catheter Ablation: CADAF-CT Trial 2.

Authors:  Yoshibumi Antoku; Masao Takemoto; Takahiro Mito; Akihiro Masumoto; Masatsugu Nozoe; Atsushi Tanaka; Yusuke Yamamoto; Takafumi Ueno; Takuya Tsuchihashi
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.